Profound Medical Corp Stock Toronto S.E.
Equities
PRN
CA74319B1067
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- CAD | - |
Sales 2024 * | 15.95M 11.67M | Sales 2025 * | 43.69M 31.98M | Capitalization | 246M 180M |
---|---|---|---|---|---|
Net income 2024 * | -38M -27.81M | Net income 2025 * | -30M -21.96M | EV / Sales 2024 * | 14.5 x |
Net cash position 2024 * | 13.74M 10.05M | Net Debt 2025 * | 41.34M 30.25M | EV / Sales 2025 * | 6.57 x |
P/E ratio 2024 * |
-6.45
x | P/E ratio 2025 * |
-7.16
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.29% |
Latest transcript on Profound Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 69 | 15-06-03 |
Rashed Dewan
DFI | Director of Finance/CFO | 56 | 15-06-30 |
Mathieu Burtnyk
COO | Chief Operating Officer | 42 | 11-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Rosenthal
BRD | Director/Board Member | 77 | 18-06-13 |
Director/Board Member | 67 | 18-06-13 | |
Cynthia Lavoie
BRD | Director/Board Member | - | 21-03-02 |
1st Jan change | Capi. | |
---|---|---|
+8.46% | 218B | |
+7.62% | 184B | |
+13.29% | 135B | |
+0.04% | 62.38B | |
+11.92% | 51.37B | |
+7.76% | 50.9B | |
+1.17% | 40.87B | |
+2.35% | 36.28B | |
+26.28% | 31.88B |
- Stock Market
- Equities
- PRN Stock
- PRN Stock